Pasithea Therapeutics Corp. (KTTA)
NASDAQ: KTTA · Real-Time Price · USD
3.100
-0.080 (-2.52%)
At close: Nov 22, 2024, 4:00 PM
3.080
-0.020 (-0.65%)
After-hours: Nov 22, 2024, 5:46 PM EST
Pasithea Therapeutics Market Cap
Pasithea Therapeutics has a market cap or net worth of $3.93 million as of November 22, 2024. Its market cap has decreased by -47.95% in one year.
Market Cap
3.93M
Enterprise Value
-5.44M
1-Year Change
-47.95%
Ranking
Category
Stock Price
$3.10
Market Cap Chart
Since the IPO on September 15, 2021, Pasithea Therapeutics's market cap has decreased from $65.29M to $3.93M, a decrease of -93.99%. That is a compound annual growth rate of -58.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 4.04M | -47.60% |
| Dec 29, 2023 | 7.71M | -58.92% |
| Dec 30, 2022 | 18.77M | -51.55% |
| Dec 31, 2021 | 38.74M | -40.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genprex | 4.17M |
| Biofrontera | 4.16M |
| Windtree Therapeutics | 4.16M |
| Hepion Pharmaceuticals | 4.06M |
| Aptorum Group | 4.05M |
| Sonoma Pharmaceuticals | 3.93M |
| Genetic Technologies | 3.78M |
| Artelo Biosciences | 3.71M |